Krystal Biotech Inc
KRYSHealthcare|Biotechnology|USA
$365.80
-5.27 (-1.42%)
DCF (FCF)
$31.98
Tangible Book
$43.37
Graham Number
$85.44
Earnings Power
$26.08
About
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Stock Price
+144.3%(1Y)
Pipeline Summary
22 total trials12
Phase 1
8
Phase 2
3
Phase 3
0
Phase 4
Completed: 4Recruiting: 11Unknown: 2Active: 2Withdrawn: 3
Active Trials (13)
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
NCT06228326Lung Cancer, Non-small Cell
Phase 1Phase 2Recruiting
Enrollment: 250 participants
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
NCT06049082Alpha 1-Antitrypsin Deficiency
Phase 1Recruiting
Enrollment: 15 participants
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
NCT05504837Cystic Fibrosis
Phase 1Recruiting
Enrollment: 20 participants
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
NCT06999733Neurotrophic Keratitis
Phase 1Phase 2Recruiting
Enrollment: 60 participants
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT06563414Epidermolysis Bullosa Dystrophica
Recruiting
Enrollment: 40 participants
BioScore
7/10
Buy
Ownership
Recent Insider Trades
Thomas John CharlesSELL
2026-06-251,000 shares @ $347.27
Krishnan SumaSELL
2026-06-0425,000 shares @ $308.11
Krishnan Krish SSELL
2026-06-0425,000 shares @ $308.12
Thomas John CharlesSELL
2026-05-26642 shares @ $302.03
Krishnan Krish SSELL
2026-03-0425,000 shares @ $263.17
Recent News
2026-06-18 15:04:58
2026-06-16 16:31:17
Data last updated: Jul 12, 2026, 07:32 PM